Electrical remodeling in atrial fibrillation

Herz

Volumn 31, Issue 2, 2006, Pages 108-112

  Dobrev, Dobromir ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Atrial fibrillation; Calcium handling; Ion channels; Mechanisms; Remodeling

Indexed keywords

ION CHANNEL;

CALCIUM HOMEOSTASIS; GAP JUNCTION; HEART ATRIUM CONDUCTION; HEART ATRIUM FIBRILLATION; HEART VENTRICLE REMODELING; HUMAN; NERVE STIMULATION; PATHOPHYSIOLOGY; REVIEW;

ACTION POTENTIALS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ATRIAL FUNCTION; CALCIUM; DISEASE MODELS, ANIMAL; DOGS; GAP JUNCTIONS; HEART ATRIA; HEART RATE; HOMEOSTASIS; HUMANS; ION CHANNELS; MUTATION; SIGNAL TRANSDUCTION;

EID: 33745127399     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-006-2787-9     Document Type: Review

References (41)

1. Anyukhovsky EP, Sosunov EA, Chandra P, et al. Age-associated changes in electrophysiologic remodeling: a potential contributor to initiation of atrial fibrillation. Cardiovasc Res 2005;66:353-63.
2. Bosch RF, Zeng X, Grammer JB, et al. Ionic mechanisms of electrical remodeling in human atrial fibrillation. Cardiovasc Res 1999;44:121-31.
3. Brundel BJ, Kampinga HH, Henning RH. Calpain inhibition prevents pacing-induced cellular remodeling in a HL-1 myocyte model for atrial fibrillation. Cardiovasc Res 2004;62:521-8.
4. Cardin S, Li D, Thorin-Trescases N, et al. Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and -independent pathways. Cardiovasc Res 2003;60:315-25.
5. Cha TJ, Ehrlich JR, Zhang L, et al. Atrial ionic remodeling induced by atrial tachycardia in the presence of congestive heart failure. Circulation 2004;110:1520-6.
6. Cha TJ, Ehrlich JR, Zhang L, et al. Dissociation between ionic remodeling and ability to sustain atrial fibrillation during recovery from experimental congestive heart failure. Circulation 2004;109:412-8.
7. Cha TJ, Ehrlich JR, Zhang L, et al. Tachycardia remodeling of pulmonary vein cardiomyocytes: comparison with left atrium and potential relation to arrhythmogenesis. Circulation 2005;111:728-35.
8. 2+ current density in chronic human atrial fibrillation is associated with increased activity of protein phosphatases. Circulation 2004;110:2651-7.
9. K,ACh is constitutively active in patients with chronic atrial fibrillation. Circulation 2005;112:3697-706.
10. K,ACh and muscarinic receptor-mediated shortening of action potentials. Circulation 2001;104:2551-7.
11. Dobrev D, Ravens U. Remodeling of cardiomyocyte ion channels in human atrial fibrillation. Basic Res Cardiol 2003;98:137-48.
12. Dobrev D, Wettwer E, Kortner A, et al. Human inward rectifier potassium channels in chronic and postoperative atrial fibrillation. Cardiovasc Res 2002;54:397-404.
13. Ehrlich JR, Cha TJ, Zhang L, et al. Characterization of a hyperpolarization-activated time-dependent potassium current in canine cardiomyocytes from pulmonary veins myocardial sleeves and left atrium. J Physiol 2004;557:583-97.
14. Gaborit N, Steenman M, Lamirault G, et al. Human atrial ion channel and transporter subunit gene-expression remodeling associated with valvular heart disease and atrial fibrillation. Circulation 2005;112:471-81.
15. Goette A, Arndt M, Rocken C, et al. Calpains and cytokines in fibrillating human atria. Am J Physiol Heart Circ Physiol 2002;283:H264-72.
16. Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339:659-66.
17. Hove-Madsen L, Llach A, Bayes-Genis A, et al. Atrial fibrillation is associated with increased spontaneous calcium release from the sarcoplasmic reticulum in human atrial myocytes. Circulation 2004;110:1358-63.
18. Jalife J, Berenfeld O, Mansour M. Mother rotors and fibrillatory conduction: a mechanism of atrial fibrillation. Cardiovasc Res 2002;54:204-16.
19. Kamp TJ, Hell JW. Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C. Circ Res 2000;87:1095-102.
20. Kostin S, Klein G, Szalay Z, et al. Structural correlate of atrial fibrillation in human patients. Cardiovasc Res 2002;54:361-79.
21. K,ACh in atrial fibrillation using a mouse knockout model. J Am Coll Cardiol 2001;37:2136-43.
22. Li D, Shinagawa K, Pang L, et al. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation 2001;104:2608-14.
23. K1 in mouse heart leads to multiple abnormalities of cardiac abnormalities. Am J Physiol Heart Circ Physiol 2004;287:H2790-802.
24. Liu L, Nattel S. Differing sympathetic and vagal effects on atrial fibrillation in dogs: role of refractoriness heterogeneity. Am J Physiol 1997;273:H805-16.
25. Nattel S. New ideas about atrial fibrillation 50 years on. Nature 2002;415:219-26.
26. Pandit SV, Berenfeld O, Anumonwo JM, et al. Ionic determinants of functional reentry in a 2-D model of human atrial cells during simulated chronic atrial fibrillation. Biophys J 2005;88:3806-21.
27. Pedersen OD, Bagger H, Kober L, et al. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. Circulation 1999;100:376-80.
28. K,ACh gradients determine unequal left/right atrial frequencies and rotor dynamics. Cardiovasc Res 2003;59:863-73.
29. Schotten U, Greiser M, Benke D, et al. Atrial fibrillation-induced atrial contractile dysfunction: a tachycardiomyopathy of a different sort. Cardiovasc Res 2002;53:192-201.
30. Shi Y, Li D, Tardif JC, et al. Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure. Cardiovasc Res 2002;54:456-61.
31. Sun H, Chartier D, Leblanc N, et al. Intracellular calcium changes and tachycardia-induced contractile dysfunction in canine atrial myocytes. Cardiovasc Res 2001;49:751-61.
32. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. The Sicilian gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Circulation 1991;84:1831-51.
33. 2+ currents and human atrial fibrillation. Circ Res 1999;85:428-36.
34. + current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation. Circ Res 1997;80:772-81.
35. Vermes E, Tardif JC, Bourassa MG, et al. Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials. Circulation 2003;107:2926-31.
36. Vest JA, Reiken SR, Wehrens XHT, et al. Defective cardiac ryanodine receptor regulation during atrial fibrillation. Circulation 2005;111:2025-32.
37. Wijffels MCEF, Kirchhof CJHJ, Dorland R, et al. Atrial fibrillation begets atrial fibrillation. A study in awake, chronically instrumented conscious goats. Circulation 1995;92:1954-68.
38. Xia M, Jin QF, Bendahhou S, et al. Kir2.1 gain-of-function mutation underlies familial atrial fibrillation. Biochem Biophys Res Commun 2005;332:1012-9.
39. Yamada M, Inanobe A, Kurachi Y. G protein regulation of potassium ion channels. Pharmacol Rev 1998;50:723-57.
40. Yamda J, Ohkusa T, Nao T, et al. Up-regulation of inositol 1,4,5 trisphosphate receptor expression in atrial tissue in patients with chronic atrial fibrillation. J Am Coll Cardiol 2001;37:1111-9.
41. Yue L, Feng J, Gaspo R, et al. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circ Res 1997;81:512-25.